Filing Details
- Accession Number:
- 0000899243-17-011976
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-05 16:05:47
- Reporting Period:
- 2017-05-03
- Filing Date:
- 2017-05-05
- Accepted Time:
- 2017-05-05 16:05:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1654403 | Yoram Palti | C/O Novocure Inc., 20 Valley Stream Pkwy Suite 300 Malvern PA 19355 | Chief Technology Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2017-05-03 | 4,000 | $11.55 | 87,825 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2017-05-04 | 4,000 | $11.29 | 83,825 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- On May 3, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.10 to $11.85. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On May 4, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.15 to $11.45. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.